Differential expression of S100 calcium-binding proteins in epidermoid cysts, branchial cysts, craniopharyngiomas and cholesteatomas

Histopathology

Volumn 42, Issue 4, 2003, Pages 387-394

  Pelc, P ^d   Vanmuylder, N ^a   Lefranc, F ^d   Heizmann, C W ^b   Hassid, S ^d   Salmon, I ^d   Kiss, R ^a   Louryan, S ^a   Decaestecker, Christine ^a,c  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c FREE UNIVERSITY OF BRUSSELS   (Belgium)

^d NONE

Author keywords

Cholesteatoma; Craniopharyngioma; Embryonic lesion; Epithelial cyst; Keratin; S100

Indexed keywords

CALCIUM BINDING PROTEIN; CALCYCLIN; CALVASCULIN; KERATIN; PROTEIN; PROTEIN S 100; PROTEIN S100A2; PROTEIN S100A3; PROTEIN S100B; UNCLASSIFIED DRUG;

ADULT; AGED; AMELOBLASTOMA; ARTICLE; BASEMENT MEMBRANE; BRANCHIOGENIC CYST; CHOLESTEATOMA; CRANIOPHARYNGIOMA; DATA ANALYSIS; EPIDERMOID CYST; EPITHELIUM CELL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE INJURY;

ADOLESCENT; ADULT; AGED; BRANCHIOMA; CHILD; CHILD, PRESCHOOL; CHOLESTEATOMA; CRANIOPHARYNGIOMA; EPIDERMAL CYST; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; PITUITARY NEOPLASMS; S100 PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 0346367185     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.2003.01588.x     Document Type: Article

References (36)

1. Burger PC, Scheithauer BW. eds. Tumors of the central nervous system. Washington DC: Armed Forces Institutes of Pathology. 1994.
2. Kleihues P, Cavenee WK, eds. World Health Organisation classification of tumors. Pathology and genetics of tumours of the nervous system. Lyon: IARC Press, 2000.
3. Miller DC. Pathology of craniopharyngiomas: clinical import of pathological findings. Pediatr. Neurosurg. 1994; 21 (Suppl. 1); 11-17.
4. Weiner HL, Wisoff JH, Rosenberg ME et al. Craniopharyngiomas: a clinicopathological analysis of factors predictive of recurrence and functional outcome. Neurosurgery 1994: 35; 1001-1010.
5. Adamson TE, Wiestler OD, Kleihues P, Yasargil MG. Correlation of clinical and pathological features in surgically treated craniopharyngiomas. J. Neurosurg. 1990: 73; 12-17.
6. Smirniotopoulos JG, Chiechi MV. Teratomas, dermoids, and epidermoids of the head and neck. Radiographics 1995: 15; 1437-1455.
7. Bhaskar S, Brenier JL. Histogenesis of branchial cysts, a report of 486 cases. Am. J. Pathol. 1958: 35; 407-423.
8. Boysen ME, de Besche A, Djupesland G, Thorud E. Internal cysts and fistulae of branchial origin. J. Laryngol. Otol. 1979: 93; 533-539.
9. Wild G, Mischke D, Lobeck H, Kastenbauer E. The lateral cyst of the neck: congenital or acquired? Acta Otolaryngol. 1987: 103; 546-550.
10. Strunk CL. Cholesteatoma. In Bailey BJ ed. Head and neck surgery - otolaryngology. Philadelphia: J.B. Lippincott Co., 1993: 1635-1646.
11. Moriyama H, Huang CC, Shirahata Y, Abramson M. Effects of keratin on bone resorption in experimental otitis media. Arch. Otorhinolaryngol. 1984: 230; 61-67.
12. Desloge R, Finstad CL, Sassoon J, Hart JC, Parisier SC, Albino AP. Altered regulation of cell surface peptidases in human cholesteatoma. Otolaryngol. Head Neck Surg. 1997: 116; 58-63.
13. Albino AP, Reed JA, Bogdany JK et al. Expression of p53 protein in human middle ear cholesteatomas. Pathogenetic implications. Am. J. Otol. 1998: 19; 30-36.
14. Shinoda H, Huang CC. Expressions of c-jun and p53 proteins in human middle ear cholesteatoma: relationship to keratinocyte proliferation, differentiation, and programmed cell death. Laryngoscope 1995: 105; 1232-1237.
15. Choufani G, Mahillon V, Decaestecker C et al. Determination of the levels of expression of sarcolectin and calcyclin and of the percentages of apoptotic but not proliferating cells to enable distinction between recurrent and nonrecurrent cholesteatomas. Laryngoscope 1999: 109; 1825-1831.
16. Choufani G, Ghanooni R, Decaestecker C et al. Detection of macrophage migration inhibitory factor (MIF) in human cholesteatomas and functional implications of correlations to recurrence status and to expression of matrix metalloproteinases-3/9, retinoic acid receptor-beta, and anti-apoptotic galectin-3. Laryngoscope 2001: 111; 1656-1662.
17. Schäfer BW, Heizmann CW. The S100 family of EF-hand calcium-binding proteins: functions and pathology. Trends Biochem. Sci. 1996: 21; 134-140.
18. Donato R. Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type. Biochim. Biophys. Acta 1999: 1450; 191-231.
19. Camby I, Nagy N, Lopes MB, Schäfer BW et al. Supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas and glioblastomas are characterized by a differential expression of S100 proteins. Brain Pathol. 1999: 9; 825-843.
20. Bronckart Y, Decaestecker C, Nagy N et al. Development and progression of malignancy in human colon tissues are correlated with expression of specific Ca(2+)-binding S100 proteins. Histol. Histopathol. 2001: 16; 707-712.
21. Föhr UG, Heizmann CW, Engelkamp D, Schäfer BW, Cox JA. Purification and cation binding properties of the recombinant human S100 calcium-binding protein A3. an EF-hand motif protein with high affinity for zinc. J. Biol. Chem. 1995: 270; 21056-21061.
22. Ilg EC, Schäfer BW, Heizmann CW. Expression pattern of S100 calcium-binding proteins in human tumors. Int. J. Cancer 1996: 68; 325-332.
23. Huang JW, Ming Z, Shrestha P et al. Immunohistochemical evaluation of the Ca2+-binding S-100 proteins S-100A1, S-100A2, S-100A4, S-100A6 and S-100B in salivary gland tumors. J. Oral Pathol. Med. 1996: 25; 547-555.
24. Schafer BW, Fritschy JM, Murmann P et al. Brain S100A5 is a novel calcium-, zinc-, and copper ion-binding protein of the EF-hand superfamily. J. Biol. Chem. 2000: 275; 30623-30630.
25. Van Eldik LJ, Jensen RA, Ehrenfried BA, Whetsell WO Jr. Immunohistochemical localization of S100 beta in human nervous system tumors by using monoclonal antibodies with specificity for the S100 beta polypeptide. J. Histochem. Cytochem. 1986: 34; 977-982.
26. Engelkamp D, Schafer BW, Mattei MG, Erne P, Heizmann CW. Six S100 genes are clustered on human chromosome 1q21: identification of two genes coding for the two previously unreported calcium-binding proteins S100D and S100E. Proc. Natl Acad. Sci. USA 1993: 90; 6547-6551.
27. Kizawa K, Uchiwa H, Murakami U. Highly-expressed S100A3, a calcium-binding protein, in human hair cuticle. Biochim. Biophys. Acta 1996: 1312; 94-98.
28. Takizawa T, Takizawa T, Arai S et al. Ultrastructural localization of S100A3, a cysteine-rich, calcium binding protein, in human scalp hair shafts revealed by rapid-freezing immunocytochemistry. J. Histochem. Cytochem. 1999: 47; 525-532.
29. Donato R. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int. J. Biochem. Cell Biol. 2001: 33; 637-668.
30. Camby I, Lefranc F, Titeca G et al. Differential expression of S100 calcium-binding proteins characterizes distinct clinical entities in both WHO Grade II and III astrocytic tumors. Neuropathol. Appl. Neurobiol. 2000: 26; 76-90.
31. Matsumoto T, Murao S, Kito K, Kihana T, Matsuura S, Ueda N. Modulation of S-100 genes response to growth conditions in human epithelial tumor cells. Pathol. Int. 1997: 47; 339-346.
32. Brinck U, Gabius HJ, Zeng FY et al. Differential expression of calcyclin and its accessible ligands in various types of cutaneous tumors. J. Dermatol. Sci. 1995: 10; 181-190.
33. Shrestha P, Muramatsu Y, Kudeken W et al. Localization of Ca(2+)-binding S100 proteins in epithelial tumours of the skin. Virchows Arch. 1998: 432; 53-59.
34. Komatsu K, Andoh A, Ishiguro S et al. Increased expression of S100A6 (calcyclin), a calcium-binding protein of the S100 family, in human colorectal adenocarcinomas. Clin. Cancer Res. 2000: 6; 172-177.
35. Stulik J, Osterreicher J, Koupilova K et al. Differential expression of the Ca2+ binding S100A6 protein in normal, preneoplastic and neoplastic colon mucosa. Eur. J. Cancer 2000: 36; 1050-1059.
36. Komatsu K, Kobune-Fujiwara Y, Andoh A et al. Increased expression of S100A6 at the invading fronts of the primary lesion and liver metastasis in patients with colorectal adenocarcinoma. Br. J. Cancer 2000: 83; 769-774.